RLI heads into its Q2 earnings today with a notable cluster of executive buying at prices well below where the stock now trades.
The insider signal is the standout. Five separate executives bought shares between May 19 and June 1, including the CEO, the COO (twice), and the independent chairman. The CEO alone spent $260,000 at $52 per share. Combined, insiders net-bought roughly 17,400 shares worth over $900,000 in the past 90 days. The stock closed Wednesday at $58.99 — meaning those buyers are already sitting on gains of roughly 13–15% in under two months. That kind of coordinated buying at a single price level is a strong vote of confidence from people with direct operational visibility.
The analyst community has shifted in the same direction since the insider purchases. Wells Fargo raised its target from $55 to $62 last week, maintaining Equal-Weight. Keefe, Bruyette & Woods lifted its Outperform target from $67 to $70. Both firms had cut targets sharply in April, so these reversals mark a genuine change in sentiment rather than routine maintenance. The mean target of $59 sits essentially at the current price, which puts the consensus debate less about valuation and more about the direction of the underlying business. Bulls point to the E&S Casualty division's 13% revenue surge on 20% higher submissions, plus surety growth from new agency relationships. Bears counter that gross written premiums fell 2% overall, property premiums dropped 11%, and casualty loss reserves appear thinner than they were — a combination that could compress underwriting margins if loss trends accelerate.
Short positioning tells a cautionary but not extreme story. Bears hold about 7.9% of the float — a meaningful level that has climbed roughly 26% over the past month, building steadily from around 5.6% of float in mid-June. That's a genuine shift in bearish conviction. Yet borrow conditions remain relaxed: cost to borrow is just 0.49%, and availability is wide at 291%, meaning there are nearly three shares available to borrow for every share currently shorted. No squeeze pressure is building on that front. Options positioning is structurally heavy on puts — the put/call ratio of 3.09 has been running near that level for weeks — but the z-score of -1.4 means today's reading is actually slightly below the recent norm, suggesting no fresh defensive surge heading into the print.
The historical reaction data is thin but worth noting: the prior quarter's print sent the stock up 6.4% on the day and nearly 11% over the following five trading days, while the quarter before that saw a 4.4% one-day drop. The print today will test whether the E&S Casualty momentum can offset property softness convincingly enough to justify both the insider conviction and the re-rating already embedded in the stock's 11% monthly gain.
See the live data behind this article on ORTEX.
Open RLI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
